Stockscreener 앱 받기
120.24
5.03%
5.76
전일 마감가:
$114.48
열려 있는:
$114.57
하루 거래량:
1.46M
Relative Volume:
1.36
시가총액:
$6.91B
수익:
$360.35M
순이익/손실:
$-149.57M
주가수익비율:
-40.62
EPS:
-2.96
순현금흐름:
$-81.27M
1주 성능:
+6.48%
1개월 성능:
+5.70%
6개월 성능:
+22.07%
1년 성능:
-23.17%
1일 변동 폭
$113.97
$121.63
1주일 범위
$93.96
$121.63
52주 변동 폭
$73.16
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
GKOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
120.24 | 6.58B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | 개시 | Goldman | Buy |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
EPS Watch: What hedge funds are buying ProShares Trust ProShares UltraShort FTSE China 50Share Buyback & Trade Opportunity Analysis - baoquankhu1.vn
Glaukos Sees Revenue Surge as Analysts Raise Price Targets - StocksToTrade
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS) - The Globe and Mail
How Glaukos’ Reaffirmed 2026 Sales Guidance and iDose TR Momentum Will Impact Glaukos (GKOS) Investors - simplywall.st
Glaukos (NYSE:GKOS) Trading 7.8% HigherHere's What Happened - MarketBeat
Glaukos Surges with Strong Year-End Financials and Optimistic Future Outlook - StocksToTrade
Glaukos Reports Preliminary Q4 and 2025 Results, Reaffirms 2026 Revenue Guidance - VisionMonday.com
Needham Reiterates Buy Rating for Glaukos (GKOS) | GKOS Stock Ne - GuruFocus
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy By Investing.com - Investing.com Australia
Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy - Investing.com Canada
Glaukos (GKOS) Shares Drop Significantly in Recent Trading - GuruFocus
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results - Investing.com Australia
Glaukos' (GKOS) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results By Investing.com - Investing.com Nigeria
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
S&P 500 Futures Fall in Premarket Trading; Glaukos, Fortinet Lag - Barron's
What 14 Analyst Ratings Have To Say About Glaukos - Benzinga
Breakout Move: What is the long term forecast for Glaukos Corporation stockPortfolio Performance Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance By Investing.com - Investing.com Nigeria
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2 - PharmiWeb.com
Glimpse Into Glaukos (GKOS): Financial Standing and Cash Reserves - GuruFocus
Glaukos Reports Strong Preliminary Q4 and 2025 Sales Growth - TipRanks
Glaukos (GKOS) Reaffirms 2026 Revenue Forecast at $600M-$620M - GuruFocus
Glaukos stock falls after preliminary Q4 sales beat estimates By Investing.com - Investing.com South Africa
Glaukos Reaffirms 2026 Revenue Guidance of $600 Million to $620 Million, Shares Fall After Hours - marketscreener.com
Glaukos stock falls after preliminary Q4 sales beat estimates - Investing.com UK
Glaukos announces preliminary, unaudited fourth quarter results - marketscreener.com
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance - Business Wire
Hedge Fund Moves: What momentum indicators show for Glaukos Corporation stock2025 Short Interest & Reliable Volume Spike Alerts - Bộ Nội Vụ
Risk Report: Is Glaukos Corporation stock a safe haven assetTrade Ideas & Safe Capital Growth Stock Tips - Bộ Nội Vụ
Gainers Report: Will Glaukos Corporation stock gain from government policiesTrade Volume Summary & Low Drawdown Investment Strategies - Bộ Nội Vụ
Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 38.10% Revenue Growth with Potential 13.86% Upside - DirectorsTalk Interviews
Understanding Momentum Shifts in (GKOS) - Stock Traders Daily
Can Glaukos Corporation stock deliver sustainable ROEWeekly Profit Recap & High Conviction Buy Zone Picks - Улправда
Why Glaukos Corporation stock is listed among top recommendations - ulpravda.ru
How Glaukos Corporation stock compares to industry benchmarksMarket Movement Recap & Daily Profit Maximizing Tips - Улправда
Why Glaukos Corporation stock could be top winnerEntry Point & Reliable Intraday Trade Alerts - ulpravda.ru
Will Glaukos Corporation stock deliver consistent dividendsJuly 2025 PreEarnings & Free Real-Time Market Sentiment Alerts - Улправда
Issuer of GKOS (GKOS) common stock files Rule 144 sale notice - Stock Titan
Technical Analysis: Is Glaukos Corporation stock supported by strong fundamentalsJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - Улправда
Is Glaukos Corporation stock supported by strong fundamentalsMarket Performance Report & Weekly Top Performers Watchlists - ulpravda.ru
Can Glaukos Corporation stock resist market sell offsTrend Reversal & Safe Entry Zone Tips - ulpravda.ru
Analysis Recap: Why Glaukos Corporation stock is listed among top recommendationsAnalyst Upgrade & Safe Swing Trade Setup Alerts - Улправда
Market Review: How geopolitical risks impact Glaukos Corporation (6GJ) stock2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
Glaukos (GKOS) director Hoffmeister granted 753 restricted stock units - Stock Titan
Glaukos (GKOS) director Marc Stapley receives 727 restricted stock units - Stock Titan
Glaukos (GKOS) director Kliman reports 623 restricted stock units granted - Stock Titan
Is Glaukos Corporation stock positioned for digital transformationMarket Sentiment Indicators & Double Digit Returns - ulpravda.ru
Published on: 2026-01-07 21:02:26 - ulpravda.ru
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):